NCT00023959 2013-02-07Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerNational Cancer Institute (NCI)Phase 1 Completed39 enrolled